← Browse by Condition
Medical Condition
infliximab
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4
NCT06839820
Recruiting
Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease
Enrollment
60 pts
Location
Norway
Sponsor
University Hospital, Akershus
NCT06051253 Phase 4
Recruiting
TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease
Enrollment
86 pts
Location
South Korea
Sponsor
Asan Medical Center